✦ LIBER ✦

O-5 Multiple regression analysis of prognostic variables for survival from the phase III study of pemetrexed versus docetaxel in non-small-cell lung cancer (NSCLC)

✍ Scribed by Hanna, Nasser; Paul, Sofia; DeMarinis, Filippo; Fossella, Frank; Salzberg, Marc; Mueller, Thomas; Shepherd, Frances; Nguyen, Binh; Kayitalire, Louis; Bunn, Paul; Einhorn, Lawrence

Book ID: 118571396
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 337 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91663-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PL-5 A phase III study of pemetrexed vs.

PL-5 A phase III study of pemetrexed vs. docetaxel in patients with advanced non-small-cell lung cancer (NSCLC) who were previously treated with chemotherapy

✍ Shepherd, Frances A.; Pereira, Jose R.; Von Pawel, Joachim; Gatzemeier, Ulrich; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

O-099 XYOTAX™ vs. docetaxel for the seco

O-099 XYOTAX™ vs. docetaxel for the second-line treatment of non-small cell lung cancer (NSCLC): The STELLAR 2 phase III study

✍ Bonomi, P.; Paz-Ares, L.; Langer, C.; O'Brien, M.; Gervais, R.; Gatzemeier, U.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P-431 Updated multiple regression analys

P-431 Updated multiple regression analysis of prognostic variables for survival in malignant pleural mesothelioma (MPM): Observations from a phase III study of pemetrexed plus cisplatin versus cisplatin and evolution of the regression model

✍ Symanowski, J.; Rusthoven, J.; Vogelzang, N. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 327 KB

PARAMOUNT: Final Overall Survival Result

PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer

✍ Paz-Ares, Luis G. (author);De Marinis, Filippo (author);Dediu, Mircea (author);T 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 209 KB

PARAMOUNT: Final Overall Survival Result

✍ Paz-Ares, Luis G. (author);De Marinis, Filippo (author);Dediu, Mircea (author);T 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 209 KB

PCN125 AN ECONOMICAL, RANDOMIZED, MULTIC

PCN125 AN ECONOMICAL, RANDOMIZED, MULTICENTER PHASE III TRIAL OF SECOND LINE TREATMENT FOR NON SMALL CELL LUNG CANCER (NSCLC) COMPARING DOCETAXEL VERSUS PEMETREXED: GFPC (GROUPE FRANÇAIS DE PNEUMO-CANCÉROLOGIE) 05–06 STUDY

✍ A Vergnenegre; R Corre; H Berard; D Paillotin; C Dujon; G Robinet; J Crequit; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB